South Africa

ViiV Healthcare's Positive Action on HIV/AIDS

Set up in 1992, Positive Action is ViiV Healthcare's international HIV/AIDS education, care and community support program. It works with community organizations to build capacity to counter the ignorance and stigma surrounding HIV and AIDS through outreach, education and advocacy. In 2009, ViiV Healthcare provided more than GBP 1 million, funding projects in 46 countries across Africa, Asia, Latin America and Eastern Europe.

ViiV Healthcare Collaborative Research Program for Resource-Poor Settings

ViiV Healthcare is committed to the development of new molecules that target unmet medical needs in HIV. The treatment of children with HIV/AIDS remains a significant unmet medical need and there is a pressing need for new medicines to tackle problems such as drug resistance, complex treatment regimens, and side effects associated with current treatments.

ViiV Healthcare Access to ARVs

In the Least Developed Countries and sub-Saharan Africa GlaxoSmithKline has offered its HIV/AIDS medicines at not-for-profit (nfp) prices since 2001. ViiV Healthcare will maintain this commitment, and will include the additional products in its portfolio. All of ViiV Healthcare's ARVs are now available at not-for-profit prices to public sector customers and not-for-profit organizations in all Least Developed Countries and all of sub-Saharan Africa - 64 countries in total.

Technology Transfer & ARV Licensing in Developing Countries

Pharmaceutical companies' preferential pricing of antiretrovirals make effective, safe, high quality HIV/AIDS treatments available to developing countries. In some cases, companies also issue voluntary licenses (VLs) which allow local manufacturers in developing countries to produce and sell generic versions of their products. VLs are not a universal solution to HIV/AIDS but a response to specific circumstances. Local factors encouraging VL use include a severe HIV/AIDS epidemic, adequate health care infrastructure, suitable economic conditions and sufficient manufacturing expertise.

Sanofi-aventis: TB Free & Other Initiatives

In March 2002, sanofi-aventis and the Nelson Mandela Foundation established the TB Free program, a EUR 15 million effort to increase detection and treatment rates for tuberculosis in South Africa. Initially planned to finish in 2007, it has now been extended to 2010. The partnership trains volunteers to encourage patient compliance during the 6-month treatment, using the WHO-recommended DOTS (Directly Observed Therapy Short-Course) strategy.

Regional Psychosocial Support Initiative

In Southern and East Africa, the Novartis Foundation aims to improve livelihoods and future prospects of children and adolescents affected by HIV/AIDS.

PMTCT: Abbott Rapid HIV Test Donation Program

Each year, approximately 800,000 babies around the world become infected with HIV during their mothers´ pregnancy, during birth or through breastfeeding.

Phelophepa Healthcare Train

The Phelophepa healthcare train provides basic healthcare services to poor patients in remote rural areas of South Africa. The train is now 16 cars long and provides a pharmacy, cancer screening and education, psychology and dental and eye clinics, as well as diabetes and smear tests. It serves more than 45,000 people a year and has reached nearly 13 million in total since its inception in 1994. The train is run by the government-owned Transnet group. The Transnet Foundation funds about two-thirds of the train's running costs and provides staff, rail access and rolling stock.

Pfizer Global Health Partnerships

Pfizer has a responsibility to direct its resources and expertise to address the world's most enduring health challenges. Cancer is one of these challenges and Pfizer recognizes that only by working together with those who share a vision of a healthier world can we make a significant impact toward eradicating this disease that has outlived too many generations. Pfizer's Global Health Partnerships (GHP) Program is one approach it is taking to tackle the global cancer epidemic.

Pfizer Global Health Fellows

The Pfizer Global Health Fellows program utilizes the professional expertise of Pfizer employees through specialized volunteer assignments with nonprofit organizations to improve health care services for underserved communities around the world. Since 2003, more than 230 employees with a range of technical skills have served in 39 nations for 3-6 month assignments investing nearly 200,000 hours of skills-based service to help increase the capacity of nonprofits organizations providing health care to the underserved (in the reporting period, 54 Global Health Fellows were deployed).

Pages